The trajectory of companies tied to Sildenafil's legacy presents a complex investment landscape. While the initial surge generated substantial returns , generic alternatives have significantly impacted https://socialwebconsult.com/story7130570/copyright-s-flagship-product-and-big-pharma-a-uncertain-venture